Publication date: Jan 22, 2020 Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the adverse events (AEs) that occur from nivolumab (Opdivo) ... Read more

Publication date: Jan 17, 2020 Because they have been found to be effective in the treatment of many types of cancer, including melanoma, immunotherapy drugs like anti-PD-1 and anti-CTLA4 should ... Read more

Publication date: Jan 17, 2020 The future of melanoma treatment will include many combinations, explained Mario Sznol, MD, professor of medicine and co-leader of cancer immunology at the Yale Cancer ... Read more

Publication date: Jan 16, 2020 Dr. Roxana Dronca discusses the treatment of advanced skin cancer and advanced genitourinary malignancies. She also highlights the transformative progress of immunotherapy in cancer treatment. ... Read more

Publication date: Jan 09, 2020 Georgina V. Long, BSc, PhD, MBBS, FRACP, co-medical director of Melanoma Institute Australia (MIA), chair of Melanoma Medical Oncology and Translational Research at MIA and ... Read more

Publication date: Jan 08, 2020 Jason J. Luke, MD, FACP, associate professor of medicine, Division of Hematology/Oncology, and director of the Cancer Immunotherapeutics Center within the Immunology and Immunotherapy Program, ... Read more

Publication date: Jan 02, 2020 Mario Sznol, MD, professor of medicine and co-leader of cancer immunology at the Yale Cancer Center, discusses the most important immunotherapy agents in the field ... Read more

Publication date: Jan 02, 2020 Mario Sznol, MD, discusses the management of patients with melanoma who progress on immune checkpoint inhibitors. Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive Concepts ... Read more

Publication date: Dec 18, 2019 In PBS’ Smart Life’s “Ask the Expert” segment, Dermatologist Dr. Ileana Perez-Quintairo answers these questions: is there such a thing as permanent filler; skin cancer ... Read more

Publication date: Dec 16, 2019 Richard A. Scolyer, BMEDSci, MBBS, Senior Staff Special in tissue pathology and diagnostic oncology, Royal Prince Alfred in Sydney, Australia, and conjoint medical director of ... Read more